Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin de Bock

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Journal of Diabetes Science and Technology|September 14, 2016
Exploration of the Performance of a Hybrid Closed Loop Insulin Delivery Algorithm That Includes Insulin Delivery Limits Designed to Protect Against HypoglycemiaMartin de Bock, Julie Dart, Anirban Roy, et al.
Diabetes Technology & Therapeutics|February 8, 2021
Impact of Hybrid Closed Loop Therapy on Hypoglycemia Awareness in Individuals with Type 1 Diabetes and Impaired Hypoglycemia AwarenessMarie-Anne Burckhardt, Mary B Abraham, Julie Dart, et al.
Diabetes Care|February 18, 2025
Association of Diabetic Ketoacidosis at Onset, Diabetes Technology Uptake, and Clinical Outcomes After 1 and 2 Years of Follow-up: A Collaborative Analysis of Pediatric Registries Involving 9,269 Children With Type 1 Diabetes From Nine CountriesKlemen Dovc, Vit Neuman, Gemulla Gita, et al.
Plos One|August 1, 2012
Psyllium supplementation in adolescents improves fat distribution & lipid profile: a randomized, participant-blinded, placebo-controlled, crossover trialMartin de Bock, José G B Derraik, Christine M Brennan, et al.
International Journal of Medical Informatics|May 30, 2025
Lifting the wellbeing of adolescents and young adults with type 1 diabetes: A feasibility study of the LIFT appAnna Serlachius, Joanna McClintock, Anna Boggiss, et al.
Plos One|March 22, 2013
Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trialMartin de Bock, José G B Derraik, Christine M Brennan, et al.
Diabetes Technology & Therapeutics|February 13, 2026
Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled TrialTom Wilkinson, Natalie Nanayakkara, David Burren, et al.
BMC Endocrine Disorders|May 22, 2019
Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocolSara E Boucher, Andrew R Gray, Martin de Bock, et al.
Journal of Diabetes and Metabolic Disorders|December 13, 2021
Study protocol: Safety and efficacy of smart watch integrated do-it-yourself continuous glucose monitoring in adults with Type 1 diabetes, a randomised controlled trialShekhar Sehgal, Martin De Bock, Jonathan Williman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 28, 2025
The usability and feasibility of a self-compassion chatbot (COMPASS) for youth living with type 1 diabetesAnna L Boggiss, Katie Babbott, Ānna Milford, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Journal of Diabetes Science and Technology|September 14, 2016
Exploration of the Performance of a Hybrid Closed Loop Insulin Delivery Algorithm That Includes Insulin Delivery Limits Designed to Protect Against HypoglycemiaMartin de Bock, Julie Dart, Anirban Roy, et al.
Diabetes Technology & Therapeutics|February 8, 2021
Impact of Hybrid Closed Loop Therapy on Hypoglycemia Awareness in Individuals with Type 1 Diabetes and Impaired Hypoglycemia AwarenessMarie-Anne Burckhardt, Mary B Abraham, Julie Dart, et al.
Diabetes Care|February 18, 2025
Association of Diabetic Ketoacidosis at Onset, Diabetes Technology Uptake, and Clinical Outcomes After 1 and 2 Years of Follow-up: A Collaborative Analysis of Pediatric Registries Involving 9,269 Children With Type 1 Diabetes From Nine CountriesKlemen Dovc, Vit Neuman, Gemulla Gita, et al.
Plos One|August 1, 2012
Psyllium supplementation in adolescents improves fat distribution & lipid profile: a randomized, participant-blinded, placebo-controlled, crossover trialMartin de Bock, José G B Derraik, Christine M Brennan, et al.
International Journal of Medical Informatics|May 30, 2025
Lifting the wellbeing of adolescents and young adults with type 1 diabetes: A feasibility study of the LIFT appAnna Serlachius, Joanna McClintock, Anna Boggiss, et al.
Plos One|March 22, 2013
Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trialMartin de Bock, José G B Derraik, Christine M Brennan, et al.
Diabetes Technology & Therapeutics|February 13, 2026
Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled TrialTom Wilkinson, Natalie Nanayakkara, David Burren, et al.
BMC Endocrine Disorders|May 22, 2019
Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocolSara E Boucher, Andrew R Gray, Martin de Bock, et al.
Journal of Diabetes and Metabolic Disorders|December 13, 2021
Study protocol: Safety and efficacy of smart watch integrated do-it-yourself continuous glucose monitoring in adults with Type 1 diabetes, a randomised controlled trialShekhar Sehgal, Martin De Bock, Jonathan Williman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 28, 2025
The usability and feasibility of a self-compassion chatbot (COMPASS) for youth living with type 1 diabetesAnna L Boggiss, Katie Babbott, Ānna Milford, et al.
Pageof 9